Stockholders’ Equity - Fair Value By Grant Date (Details) - $ / shares |
1 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Sep. 30, 2021 |
Jul. 31, 2021 |
Apr. 30, 2021 |
Dec. 31, 2020 |
Oct. 31, 2020 |
Jul. 31, 2020 |
Mar. 31, 2020 |
Dec. 31, 2022 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
| Number of options granted (in shares) | 580,590 | 1,610,102 | 249,067 | 2,371,893 | 346,250 | 414,149 | 502,016 | 0 |
| Fair value (in dollars per share) | $ 8.6490 | $ 9.1387 | $ 9.8159 | $ 9.3857 | $ 6.5353 | |||
| Minimum | ||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
| Fair value (in dollars per share) | $ 6.7118 | $ 8.3377 | ||||||
| Maximum | ||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
| Fair value (in dollars per share) | $ 10.1240 | $ 8.4404 | ||||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|